General Info

General Info

General Info - Col 1

Study Details

Study ID PD055_05_05
Data Set ID PD055_05_05
Model 3D InSightâ„¢ Human NASH Model (multi-donor hepatocytes cocultured with Kupffer cells, liver endothelial cells and hepatic stellate cells)
Study Objective To investigate gene expression changes in 3D InSightâ„¢ Human NASH Model upon treatment with ALK5 inhibitor and PPAR agonist
Study Design LEAN and NASH modelling (high sugar levels, free fatty acids, LPS pulse). NASH-induced microtissues treated with ALK5 inhibitor or PPAR agonist. Total treatment time - 10 days. Samples collected at day 10
Sequencing Technology Human Whole Transcriptome (WT) TempO-Seq Assay
Analysis Pipeline Version v2.1
Analysis Package BASIC
Time Stamp 2023-08-25 12:16:37

Quick Guide

  • This RNA-Seq report is a self-contained HTML document.

  • For the best viewing experience, the following web browsers are recommended: Google Chrome, Mozilla Firefox and Microsoft Edge.

  • The minimal supported display resolution is 1280 × 720 pixels.

General Info - Col 2